
Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis
Author(s) -
AnnaLuisa Luger,
Sven König,
Patrick Felix Samp,
H. Urban,
Iris Divé,
Michael C. Burger,
Martin Voß,
Kea Franz,
Emmanouil Fokas,
Katharina Filipski,
Melanie-Christin Demes,
Albrecht Stenzinger,
Felix Sahm,
David Reuß,
Patrick N. Harter,
Sebastian Wagner,
Elke Hattingen,
Jennifer Wichert,
Constantin Lapa,
Stefan Fröhling,
Joachim P. Steinbach,
Michael Ronellenfitsch
Publication year - 2022
Publication title -
journal of neuro-oncology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.256
H-Index - 114
eISSN - 1573-7373
pISSN - 0167-594X
DOI - 10.1007/s11060-022-04049-w
Subject(s) - tolerability , medicine , oncology , targeted therapy , adverse effect , ros1 , progressive disease , disease , cancer , adenocarcinoma